Description
Syntex Pharma AOD+FRAG is a dual-peptide formulation combining AOD-9604 and HGH Fragment 176-191, two peptides widely studied for their interaction with fat metabolism, lipolysis, and metabolic regulation pathways. This research blend is commonly investigated for its potential role in body composition, adipose tissue biology, and energy metabolism.
Each pack contains 5 vials, with a total peptide content of 3 mg per vial. Syntex Pharma AOD + FRAG is supplied in a lyophilized format and is intended for research applications involving peptide science, metabolic biology, and body composition studies.
Key Features
- Dual-peptide formulation
- AOD-9604 + HGH Fragment 176-191 blend
- Total peptide content: 3 mg per vial
- 5 vials per pack
- Lyophilized peptide format
- Studied for fat metabolism and lipolysis pathways
- Research-focused peptide compound
Contents
- Active Ingredients: AOD-9604 + HGH Fragment 176-191 – Total 3 mg
- Quantity: 5 Vials
AOD + FRAG, AOD-9604, HGH Fragment 176-191, Syntex Pharma AOD + FRAG, Syntex Pharma, AOD 9604 Peptide, HGH Frag 176-191, Fat Metabolism Research, Lipolysis Research, Body Composition Research, Metabolic Research, Peptide Research, Lyophilized Peptide, Research Compound, 3 mg Vial, 5 Vials, Laboratory Research, Syntex Pharma Products
Reviews
There are no reviews yet.